I am a
Home I AM A Search Login

Papers of the Week

2022 Aug 26

J Dermatolog Treat

Impact of Secukinumab on Patient-Reported Outcomes in Biologic-Naive Patients With Psoriasis in a US Real-World Setting.


Strober B, Patil D, McLean RR, Moore-Clingenpeel M, Guo N, Levi E, Lebwohl M
J Dermatolog Treat. 2022 Aug 26:1-37.
PMID: 36026543.


To describe real-world baseline characteristics and patient-reported outcomes (PROs) at 6- and 12-month follow-up visits among patients with psoriasis who initiated and maintained secukinumab, stratified by prior exposure to biologics.